Biomarkers.

Area of Science:

• Neuroscience
• Biomarker Research
• Clinical Diagnostics

Background:

• Blood biomarkers, particularly pTau-217, are crucial for Alzheimer's disease (AD) diagnosis and management.
• pTau-217 shows high sensitivity and specificity for identifying AD pathology.
• Co-morbidities can influence blood biomarker levels, leading to potential misclassifications.

Purpose of the Study:

• To explore short-term fluctuations in blood biomarkers for AD.
• To identify potential drivers of these fluctuations, such as alcohol consumption and exercise.
• To characterize the analytical and biological variation of pTau-217 assays.

Main Methods:

• The Draw-10 study enrolled approximately 100 participants aged 50-80 with normal cognition or mild cognitive impairment.
• Participants provided 10 plasma samples over 9 weeks, reporting weekly alcohol use and exercise.
• pTau-217 assays of different designs were assessed to evaluate variations.

Main Results:

• Results will estimate analytical and biological variation for pTau-217 assays.
• The study will determine reference change values and the frequency of major blood biomarker fluctuations.
• Potential attenuation of fluctuations by different assay designs or ratios will be investigated.

Conclusions:

• The Draw-10 study aims to enhance the understanding of biological variation in AD blood biomarkers.
• Findings may improve biomarker-supported clinical decisions and prevent misinterpretations in research screening.
• The study will help determine the minimum number of samples needed for reliable pTau-217 measurements.